RESEARCH
A Community‐Based Screening Initiative to Identify Mothers at Risk for Postpartum Depression

https://doi.org/10.1111/j.1552-6909.2010.01199.xGet rights and content

ABSTRACT

Objectives

To conduct a community‐based, postpartum depression (PPD) screening initiative, and recommend PPD screening practices.

Design

Descriptive correlational.

Settings

Two academic medical centers, a university research office, and participants' homes.

Participants

Five thousand one hundred and sixty‐nine postpartum women age 14 to 49 years.

Methods

The Agency for Healthcare Research and Quality (AHRQ) framework was implemented by identifying a cohort of mothers and conducting PPD screening followed by diagnostic evaluation of those with positive screens. Mothers in the postpartum period were recruited from two academic medical centers and screened for PPD at 4 to 6 weeks postpartum by telephone or mail using the Edinburgh Postnatal Depression Scale (EPDS). Mothers with EPDS scores ≥10 were invited to participate in the Structured Clinical Interview for DSM IV (SCID) to confirm PPD.

Results

Six hundred and seventy‐four (13%) women had EPDS scores ≥10; 185 women with elevated EPDS scores agreed to have a SCID diagnostic interview, and 144 were diagnosed with minor or major depression. A significantly higher percentage of women who self‐administered and mailed in the EPDS than women who were screened via telephone had scores ≥10. Elevated PPD scores were not associated with age or parity. Race/ethnicity identification other than White and having less than high school education were associated with higher PPD scores.

Conclusions

The AHRQ framework was effective in guiding a large‐scale PPD screening initiative by identifying mothers at risk for PPD. Results support previous findings regarding prevalence, selected risk factors, and continued use of the EPDS with SCID confirmation.

Section snippets

Background and Significance

Postpartum depression is a common childbirth complication with documented prevalence estimated at 13% (13, 14, 22, 23). Although combinations of risk factors are likely to contribute to any individual woman's vulnerability to PPD, accumulating evidence suggests that PPD affects a cross‐section of women and that factors such as prenatal depression and history of maternal depression, current stress, poor quality of relationships, young age, very low socioeconomic status or education, and possibly

Theoretical Framework

The CARE screening design followed the Agency for Healthcare Research and Quality (AHRQ) framework recommended by Gaynes et al. (2005) in their evidence report on the impact of PPD screening, intervention, and patient outcomes. This framework begins by identifying a cohort of mothers in the postpartum period with unknown mood state, follows with formal postpartum screening using a valid measure, proceeds with clinical diagnostic evaluation for those with positive screens, employs random group

Methods

The research reported here makes up Phase 1 of the study, CARE Intervention for Depressed Mothers and Their Infants. Phase 1 involved recruiting, screening, and diagnostic evaluation of postpartum women to determine depression status and eligibility for enrollment in the randomized clinical trial (RCT). Results presented here include a description of the key features of an effective PPD screening protocol for women in the community, prevalence rates obtained for telephone and mail‐in screening

Measures

Edinburgh Postnatal Depression Scale (EPDS). The EPDS (Cox, 1986; Cox et al., l987) was designed specifically to identify symptoms of PPD and is the most widely used PPD screening instrument with community‐based populations in the United States and internationally (13, 14). The EPDS was used in the current study to identify mothers who were at risk for PPD. The EPDS consists of 10 statements describing depressive symptoms with some reverse‐coded items with four possible responses, each scored

Procedures

The study protocol was approved by Partners Health Care Human Subjects Committee and the Boston College Human Subjects Committee. Following PPD screening for possible RCT eligibility, the research nurse explained the study and asked mothers with positive PPD screening scores if they were willing to have an advanced practice registered nurse (APRN) make a home visit for a follow‐up assessment interview (i.e., the SCID). For willing mothers, formal informed consent was obtained by the APRN at

Follow‐Up Procedures

During screening, and at any point in the 9‐month clinical trial, whenever a mother's depression score was in the moderate to severe symptom range (i.e., EPDS ≥13) or her response to EPDS Item 10 (that indicated thoughts of self‐harm) was positive (i.e.,hardly ever, sometimes, oryes quite often), the research nurse determined whether the mother was currently receiving any mental health treatment and subsequently encouraged the mother to contact her clinician immediately. If the mother was not

PPD Screening and Prevalence

CARE study nurses received signed PCFs from 7,212 mothers that indicated permission to contact these mothers at 4 weeks postpartum. Figure 1 details the disposition of the 7,212 mothers. Of these 7,212 mothers, 3,018 (42%) mothers received their questionnaires in the mail and 3,806 (53%) were screened by telephone. Of those who received mailed forms, 1,363 (19% of the total population) sent them back and 1,655 (23% of the total population) did not. In addition, 88 (1.2%) women returned opt‐out

SCID Diagnostic Interview Results

Of the 674 mothers with positive screens, 268 (39%) agreed to be considered for the Phase 2 9‐month RCT and 267 (39%) declined, 74 (11%) mothers were deemed to be too late with respect to study timelines, 52 (9%) mothers were not reached by phone or mail, and 16 (2%) mothers did not meet inclusion criteria. The available data elicited from mothers indicated that reasons for declining to participate and/or not completing the diagnostic interview visit included being unable to schedule the home

Discussion and Implications

In the screening (Phase 1) of the CARE study mothers with unknown mood state were screened for PPD and those with positive screens who agreed then participated in diagnostic evaluation. Willing mothers who qualified were subsequently randomly assigned for participation in the RCT (Phase 2), and referred for treatment options as necessary during follow‐up. Feasibility of the AHRQ framework was validated, as more than 5,000 mothers were willingly screened for PPD with the EPDS. Because mothers in

Conclusions

In summary, results presented here demonstrate that mothers were receptive to PPD screening, by telephone and by mail. The risk factors identified add to the growing knowledge about mothers who may be at increased risk for PPD. Our findings reinforce the recommendations of Gaynes et al. (2005) for continued research to test the effectiveness of methods for routine PPD screening, including examination of whether health outcomes are improved through such screening efforts. The success of our PPD

Acknowledgments

Funded by CARE Intervention for Depressed Mothers and Their Infants, National Institutes of Health, National Institute for Nursing Research Grant #R01 NR008033 (2004‐2010).

REFERENCES (34)

  • D.D. Affonso et al.

    An international comparative study exploring postpartum depression symptoms

    Journal of Psychosomatic Research

    (2000)
  • S.S. Fergerson et al.

    Diagnosing postpartum depression

    American Journal of Obstetrics and Gynecology

    (2002)
  • Diagnostic and statistical manual of mental disorders

    (2000)
  • C.T. Beck

    A meta‐analysis of predictors of postpartum depression

    Nursing Research

    (1996)
  • C.T. Beck

    Maternal depression and child behavior problems

    Journal of Advanced Nursing

    (1999)
  • C.T. Beck

    Predictors of postpartum depression

    Nursing Research

    (2001)
  • C.T. Beck et al.

    Postpartum depression screening scale

    Nursing Research

    (2000)
  • M. Beeghly et al.

    Prevalence, stability, and socio‐demographic correlates of depressive symptoms in black mothers during the first 18 months postpartum

    Maternal Child Health

    (2003)
  • L.H. Chaudron et al.

    Detection of postpartum depression at well‐child visits

    Pediatrics

    (2004)
  • J.L. Cox

    Postnatal depression: A guide for health professionals

    (1986)
  • J.L. Cox et al.

    Detection of postnatal depression

    British Journal of Psychiatry

    (1987)
  • M.B. First et al.

    Structured clinical interview for DSM‐IV axis disorders (SCID‐1): Clinician version administration booklet: Biometrics Research Department

    (1997)
  • B.N. Gaynes et al.

    Perinatal depression

    Agency for Healthcare Research and Quality

    (2005)
  • J. Gibson et al.

    A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women

    Acta Psychiatrica Scandinavica

    (2009)
  • J.A. Horowitz et al.

    Promoting responsiveness between mothers with depressive symptoms and their infants

    Journal of Nursing Scholarship

    (2001)
  • J.A. Horowitz et al.

    Postpartum depression

    Journal of Perinatology

    (1995)
  • J.A. Horowitz et al.

    Community‐based postpartum depression screening

    Psychiatric Services

    (2009)
  • Cited by (53)

    • Changing risk factors for postpartum depression in mothers admitted to a perinatal center

      2023, Pediatrics and Neonatology
      Citation Excerpt :

      A study of a Japanese regional cohort24 and a prospective study of mothers whose infants were hospitalized in the NICU in other developed countries25 reported that maternal aging was associated with an increased risk of PPD. However, path model analysis in mainland China26 and Israel27,28 showed that younger maternal age was a risk factor for PPD. Other community-based or regional cohort studies did not report maternal age as a risk factor for PPD.29

    • Vitamin D: Effects on human reproduction, pregnancy, and fetal well-being

      2018, Journal of Steroid Biochemistry and Molecular Biology
    • Nurse-Led Initiatives to Implement Universal Screening for Perinatal Emotional Complications

      2017, Nursing for Women's Health
      Citation Excerpt :

      Although screening for other complications of pregnancy, such as gestational diabetes, has become the standard of care in all settings, screening for psychiatric disorders has not. The body of literature on the topic suggests that even when maternity care providers do use a screening tool, implementation, documentation, and interventions are inconsistent (Farr et al., 2014; Horowitz, Murphy, Gregory, & Wojcik, 2011; Schaar & Hall, 2013). As a result, women are likely to fall through the cracks.

    View all citing articles on Scopus
    View full text